A global venture capital firm has encountered a cyber incident leading to potential data exposure and disruption in business operations. The firm is working diligently to mitigate the impact of the incident and ensure the security of their systems and information.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, a biotech company with three approved gene therapies but no way of commercialising them, will be sold to private equity firms Carlyle and
